MAM
DGX icon

Madison Asset Management’s Quest Diagnostics DGX Stock Holding History

Madison Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,562
Closed -$1.44M – 349
2025
Q3 		$1.44M Sell
7,562
-2,280
-23% -$405K 0.02% 267
2025
Q2 		$1.77M Sell
9,842
-180
-2% -$31.3K 0.02% 250
2025
Q1 		$1.7M Buy
10,022
+2,205
+28% +$362K 0.02% 247
2024
Q4 		$1.18M Buy
7,817
+142
+2% +$22.1K 0.01% 275
2024
Q3 		$1.19M Buy
+7,675
New +$1.15M 0.01% 279
2020
Q2 		– Sell
-24,600
Closed -$1.98M – 274
2020
Q1 		$1.98M Buy
+24,600
New +$2.55M 0.04% 202

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Madison Asset Management's DGX Position: Q4 2025 in Review

Madison Asset Management sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 7,562 shares — an estimated $1.44M sold.

Madison Asset Management first reported a position in DGX in Q1 2020 and held it in 6 quarters. The position peaked at $1.98M in Q1 2020. 1,049 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • Madison Asset Management reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
  • Madison Asset Management sold 7,562 Quest Diagnostics shares in Q4 2025, an estimated $1.44M.
  • Madison Asset Management first reported a position in Quest Diagnostics in Q1 2020 and held it in 6 quarters.
  • Madison Asset Management's Quest Diagnostics position peaked at $1.98M in Q1 2020.
  • 1,049 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on Madison Asset Management's 13F filing for Q4 2025, filed 4 Feb 2026.